Clinical Effectiveness of the 0.19-mg Fluocinolone Acetonide (FAc) Intravitreal Implant for Diabetic Macular Edema: Anatomic, Visual and Treatment Burden Outcomes

被引：0
|
作者：
Morozova, Christine [1 ]
Humayun, Lucas [1 ,2 ]
Tabandeh, Homayoun [1 ]
Boyer, David S. [1 ]
Dayani, Pouya N. [1 ,3 ]
Rahhal, Firas M. [1 ,3 ]
机构：
[1] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[2] Duke Univ, Durham, NC USA
[3] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2652
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema
    Merrill, Pauline T.
    Holekamp, Nancy
    Roth, Daniel
    Kasper, Jonathan
    Grigorian, Ruben
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 248 : 16 - 23
  • [2] The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus
    Kolomeyer, Anton M.
    Eichenbaum, David A.
    Kiernan, Daniel F.
    Suner, Ivan J.
    Hariprasad, Seenu M.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2023, 54 (03): : 166 - +
  • [3] The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema (vol 248, pg 16, 2023)
    Merrill, Pauline T.
    Holekamp, Nancy
    Roth, Daniel
    Kasper, Jonathan
    Grigorian, Ruben
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 252 : 336 - 336
  • [4] BETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA
    Gonzalez, Victor
    Luo, Caesar
    Almeida, David R. p.
    Cutino, Antonio
    Coughlin, Brandon
    Kasper, Jonathan F.
    Kiernan, Daniel
    PALADIN Study Grp
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (08): : 1301 - 1307
  • [5] Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
    Lea F. Weber
    Stefanie Marx
    Gerd U. Auffarth
    Alexander F. Scheuerle
    Tamer Tandogan
    Christian Mayer
    Ramin Khoramnia
    Journal of Ophthalmic Inflammation and Infection, 9
  • [6] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2018, 7 : 293 - 305
  • [7] Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
    Weber, Lea F.
    Marx, Stefanie
    Auffarth, Gerd U.
    Scheuerle, Alexander F.
    Tandogan, Tamer
    Mayer, Christian
    Khoramnia, Ramin
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2019, 9 (1)
  • [8] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Yahiya Y. Syed
    Drugs, 2017, 77 : 575 - 583
  • [9] Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)
    Liu, John
    Coney, Joseph
    Schartman, Jerome
    Miller, David G.
    Zegarra, Hernando
    Rao, Llewelyn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [10] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Syed, Yahiya Y.
    DRUGS, 2017, 77 (05) : 575 - 583
12345